This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of hypopharynx
C3_HYPOPHARYNX
hypopharynx cancer: A primary or metastatic malignant neoplasm that affects the hypopharynx.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
163 |
4. Check minimum number of eventsNone |
163 |
5. Include endpoints |
163 |
6. Filter based on genotype QC (FinnGen only) |
148 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of hypopharynx
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of hypopharynx, including Hilmo
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, including Hilmo
- Solid cancers
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 148 | 17 | 131 |
| Unadjusted period prevalence (%) | 0.05 | 0.01 | 0.06 |
| Median age at first event (years) | 69.29 | 69.73 | 69.23 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 151
- Matched controls
- 1510
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
143.6
114
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
732.8
116.8
101
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
712.0
115.4
100
*
UJC01
NOMESCO Finland
Scopy of lower throat
313.1
108.0
99
9
A03FA01
ATC
metoclopramide; systemic, rectal
27.1
96.9
89
76
WF002
NOMESCO Finland
Radical radiotherapy
+∞
92.4
79
*
8070/3-C13.9
ICD-O-3
Squamous cell carcinoma, NOS, of hypopharynx, NOS
+∞
88.5
76
*
C13.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of hypopharynx
+∞
83.2
72
*
XX3DW
NOMESCO Finland
Time consuming IT work
28.9
65.3
48
24
N02AA05
ATC
oxycodone; systemic
14.9
64.8
85
120
C13.9
ICD-10 Finland
Malignant neoplasm: Hypopharynx, unspecified
+∞
63.0
56
*
R4190
NOMESCO Finland
Nutritional therapy
37.1
62.2
41
15
Z51.5
ICD-10 Finland
Palliative care
20.9
55.3
47
32
EP1AE
NOMESCO Finland
Neck ultrasound examination
23.6
49.8
39
22
H02AB02
ATC
dexamethasone; systemic
115.9
46.1
48
6
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
42.8
39
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
10.8
38.2
50
66
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
69.6
36.7
41
8
UDQ12
NOMESCO Finland
Flexible laryngoscopy
12.0
36.0
42
47
GBB00
NOMESCO Finland
Tracheostomy
93.6
33.6
36
5
GD1AD
NOMESCO Finland
Thorax CT examination
10.9
32.9
41
50
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
32.5
30
*
C12
ICD-10 Finland
Malignant neoplasm of piriform sinus
+∞
31.3
29
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
31.3
29
*
UJC02
NOMESCO Finland
Rigid oesophagoscopy
104.5
31.2
33
*
EBA15
NOMESCO Finland
Extraction of multiple teeth
14.2
31.0
31
27
WZC00
NOMESCO Finland
Treatment plan or consultation
6.7
31.0
82
227
A04AA01
ATC
ondansetron; systemic, rectal
45.0
29.0
35
10
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
341.1
28.8
28
*
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
341.1
28.8
28
*
D10.7
ICD-10 Finland
Benign neoplasm: Hypopharynx
+∞
28.0
26
*
C13.1
ICD-10 Finland
Malignant neoplasm: Aryepiglottic fold, hypopharyngeal aspect
+∞
28.0
26
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
28.0
26
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
118.7
27.7
29
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
26.9
25
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
10.5
26.8
33
39
R13
ICD-10 Finland
Dysphagia
8.6
26.6
40
61
C13.2
ICD-10 Finland
Malignant neoplasm: Posterior wall of hypopharynx
+∞
25.8
24
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
25.8
24
*
WZC30
NOMESCO Finland
Teaching
6.4
24.4
52
114
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
7.6
24.2
41
71
UDH02
NOMESCO Finland
Rhinopharyngoscopy
8.6
24.1
35
51
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
23.5
22
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
99.2
23.5
25
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
23.1
23.0
33
18
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
22.4
21
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
22.4
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
22.4
21
*
WX408
NOMESCO Finland
General anesthesy, balanced
5.3
22.4
66
192
C13.0
ICD-10 Finland
Malignant neoplasm: Postcricoid region
+∞
21.3
20
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
21.3
20
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
85.0
20.3
22
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
228.7
20.1
20
*
UDQ22
NOMESCO Finland
Microlaryngoscopy
44.8
19.2
23
6
8070/3-C12.9
ICD-O-3
Squamous cell carcinoma, NOS, of pyriform sinus
+∞
19.2
18
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
18.1
17
*
R07.0
ICD-10 Finland
Pain in throat
8.7
17.5
24
32
A06AD11
ATC
lactulose; oral
4.8
17.3
52
150
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.2
17.1
34
68
8070/3-C13.2
ICD-O-3
Squamous cell carcinoma, NOS, of posterior wall of hypopharynx
+∞
17.0
16
*
DQA10
NOMESCO Finland
Biopsy of larynx
101.5
17.0
18
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
17.2
16.6
26
18
WX002
NOMESCO Finland
Sedation and analgesia
4.5
16.5
54
166
ZXE00
NOMESCO Finland
One hour or less
4.0
16.2
82
344
WX402
NOMESCO Finland
General anaesthesia
4.5
16.1
53
163
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
15.9
15
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.9
15
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
177.6
15.8
16
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
177.6
15.8
16
*
EBA10
NOMESCO Finland
Operative extraction of tooth
6.2
15.6
30
58
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.9
15.4
86
382
UJC12
NOMESCO Finland
Flexible oesophagoscopy
50.7
15.4
18
*
WW500
NOMESCO Finland
Blood transfusion
28.5
15.1
20
8
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
14.8
14
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
14.8
14
*
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
47.5
14.4
17
*
JN4AD
NOMESCO Finland
Body CT examination
6.1
14.0
27
52
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
13.7
13
*
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
+∞
13.7
13
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
153.2
13.7
14
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
12.7
12
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.7
12
*
ENA10
NOMESCO Finland
Biopsy of pharynx
+∞
12.7
12
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
141.2
12.6
13
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.5
12.6
67
281
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
10.8
12.6
24
26
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.1
12.1
40
121
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
11.6
11
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
11.6
11
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
11.6
11
*
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
+∞
11.6
11
*
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
129.5
11.6
12
*
UDQ02
NOMESCO Finland
Direct laryngoscopy
38.3
11.5
14
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
64.7
10.8
12
*
A07AA02
ATC
nystatin; oral
9.3
10.8
22
27
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
+∞
10.5
10
*
TGB20
NOMESCO Finland
Tracheostomy tube replacement
+∞
10.5
10
*
A04AD12
ATC
aprepitant; systemic
+∞
10.5
10
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.9
10.4
36
112
A02BC05
ATC
esomeprazole; systemic
3.0
9.8
79
409
ZXD10
NOMESCO Finland
Scheduled procedure
3.0
9.8
71
347
K22.2
ICD-10 Finland
Oesophageal obstruction
58.9
9.8
11
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
4.4
9.7
27
71
JN4BD
NOMESCO Finland
Extensive body CT
5.7
9.6
19
37
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
106.4
9.5
10
*
8070/3-C13.1
ICD-O-3
Squamous cell carcinoma, NOS, of hypopharyngeal aspect of aryepiglottic fold
+∞
9.5
9
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
+∞
9.5
9
*
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
+∞
9.5
9
*
R21
ICPC
Throat symptom/complaint
3.8
9.4
33
103
SAA03
NOMESCO Finland
Extended examination of mouth
2.9
9.2
66
318
SCA02
NOMESCO Finland
Preventive oral health care
5.4
9.1
19
39
RD210, ,
NOMESCO Finland
20.1
9.1
13
7
N05CF01
ATC
zopiclone; oral
2.9
9.0
66
322
R4110
NOMESCO Finland
Physiotherapy
3.0
8.9
52
223
ZXE10
NOMESCO Finland
More than one and less than three hours
2.9
8.8
64
309
Z3226
NOMESCO Finland
Physiotherapist
3.4
8.7
37
131
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
10.4
8.5
16
17
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
8.5
32
105
D77
ICPC
Malignant digestive neopl other/NOS
+∞
8.4
8
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
ENB30
NOMESCO Finland
Laryngopharyngectomy
+∞
8.4
8
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
9.0
8.3
17
21
ZXD05
NOMESCO Finland
Urgent procedure
2.8
8.3
60
288
K02.1
ICD-10 Finland
Caries of dentine
2.7
8.2
92
550
Z2446
NOMESCO Finland
Social worker
6.8
8.2
20
33
ZZA00
NOMESCO Finland
Split skin graft
10.3
8.0
15
16
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.8
7.8
16
20
ZXB10
NOMESCO Finland
Medial
47.5
7.8
9
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
47.5
7.8
9
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
84.0
7.5
8
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
7.3
7
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
7.3
7
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
7.3
7
*
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
+∞
7.3
7
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
7.3
7
*
JDB00
NOMESCO Finland
Gastrostomy
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
DQB30
NOMESCO Finland
Laryngectomy
+∞
7.3
7
*
GBB13
NOMESCO Finland
Revision of tracheostomy
+∞
7.3
7
*
N06AX11
ATC
mirtazapine; oral
2.6
7.1
59
299
Z3231
NOMESCO Finland
Registered nurse
2.6
6.6
49
234
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
15.2
6.5
10
7
L03AA02
ATC
filgrastim; parenteral
72.8
6.5
7
*
RD160, ,
NOMESCO Finland
72.8
6.5
7
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
6.4
44
202
N05BA02
ATC
chlordiazepoxide; systemic
9.9
6.4
12
13
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
6.4
89
565
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
11.7
6.4
11
10
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
28.0
6.3
8
*
GD6AD
NOMESCO Finland
CT of chest and neck
28.0
6.3
8
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
28.0
6.3
8
*
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
+∞
6.3
6
*
C14.0
ICD-10 Finland
Malignant neoplasm: Pharynx, unspecified
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
+∞
6.3
6
*
Z93.1
ICD-10 Finland
Gastrostomy status
+∞
6.3
6
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
N07BB01
ATC
disulfiram; oral
4.5
6.3
16
39
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
7.8
6.1
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
33
14
29.72
24.78
1.5
1.1
—
—
—
0
0
72
286
3.90
15.21
3.2
2.1
—
—
—
0
0
94
528
3.07
10.14
3.6
2.5
—
—
estimate
—
0
0
104
637
3.03
9.26
14.4
6.2
4.92
4.40
e9/l
1.24
90
558
26
82
3.62
7.25
1.8
1.4
—
—
—
0
0
49
239
2.55
6.31
2.2
1.9
—
—
—
0
0
87
560
2.31
5.90
8.9
6.2
1.19
1.20
mmol/l
0.74
82
521
38
180
2.48
5.11
2.2
1.8
—
—
—
0
0
36
168
2.50
4.98
2.1
1.9
—
—
—
0
0
27
114
2.67
4.55
4.8
1.6
418.04
399.71
nmol/l
0.19
27
106
89
621
2.05
4.45
9.1
6.7
1.19
1.20
mmol/l
0.27
74
547
28
122
2.59
4.44
2.6
2.0
2.04
1.78
%
0.46
20
105
22
87
2.79
4.19
1.8
1.6
—
—
—
0
0
98
1197
0.48
4.12
4.2
6.6
2.33
2.46
mmol/l
0.64
86
1107
94
1164
0.49
4.12
3.5
5.6
1.41
1.35
mmol/l
0.60
85
1072
95
1170
0.49
4.03
3.5
5.7
4.16
4.29
mmol/l
0.54
89
1089
26
116
2.50
3.92
1.3
1.3
—
—
—
0
0
94
1156
0.51
3.81
4.7
7.5
38.07
40.54
mmol/mol
1.68
84
1087
61
852
0.52
3.65
3.8
4.3
1.77
2.00
ug/l
0.45
54
768
92
1126
0.53
3.36
3.2
4.7
1.15
1.30
mmol/l
1.58
84
1029
31
515
0.50
3.01
1.7
2.0
1.08
1.32
mmol/l
2.14
26
427
54
354
1.82
2.94
2.9
2.9
0.15
0.36
e6/l
1.58
43
252
8
20
4.16
2.60
1.5
1.3
—
—
—
0
0
8
20
4.16
2.60
1.5
1.3
—
—
—
0
0
24
126
2.08
2.48
5.0
3.1
—
—
—
0
0
30
469
0.55
2.25
3.3
4.0
0.00
0.00
estimate
—
10
100
35
522
0.57
2.21
2.7
4.5
11.32
10.91
mg/mmol
0.03
24
352
55
391
1.64
2.14
4.2
2.3
59.90
68.14
u/l
0.25
49
371
33
208
1.75
1.99
2.6
2.9
0.83
1.48
e6/l
0.40
18
100
102
1166
0.61
1.99
4.7
5.6
5.93
6.13
mmol/l
1.18
92
1057
7
169
0.39
1.93
10.3
7.1
—
—
—
0
0
8
28
2.96
1.89
1.4
1.2
—
—
—
0
0
53
692
0.64
1.83
3.6
3.9
22.52
25.07
%
0.42
24
331
34
225
1.66
1.72
2.6
2.6
0.47
1.01
e6/l
1.26
19
118
8
31
2.67
1.68
1.3
1.7
—
—
—
0
0
7
25
2.88
1.67
1.0
1.3
—
—
—
0
0
47
341
1.55
1.63
2.1
2.1
2.94
2.76
mg/l
0.22
39
289
47
617
0.65
1.60
2.9
3.9
0.00
0.00
estimate
-0.00
11
123
10
44
2.36
1.59
1.0
1.2
9.80
10.65
g/l
—
10
36
21
333
0.57
1.59
3.5
3.5
0.00
0.00
estimate
—
10
92
12
58
2.16
1.54
2.1
1.7
—
—
—
0
0
6
21
2.93
1.52
1.2
2.0
—
—
—
0
0
7
29
2.48
1.41
1.3
1.8
—
—
—
0
0
9
41
2.27
1.39
1.0
1.1
—
111.82
—
0
13
49
625
0.68
1.39
2.8
3.9
0.00
0.04
estimate
0.50
11
109
11
55
2.08
1.31
2.0
1.6
—
—
—
0
0
48
606
0.70
1.25
2.8
3.9
0.00
0.00
estimate
-0.00
11
119
14
79
1.85
1.21
1.5
1.5
—
—
—
0
0
30
210
1.53
1.21
8.5
6.8
102.13
104.34
mmol/l
1.46
30
210
8
40
2.05
1.14
1.0
1.2
0.00
0.00
g/l
—
8
32
5
21
2.43
1.10
1.0
1.0
—
—
—
0
0
10
54
1.91
0.99
1.0
1.2
3.67
3.79
g/l
—
10
46
10
54
1.91
0.99
1.0
1.2
3.96
4.17
g/l
—
10
46
10
54
1.91
0.99
1.0
1.2
8.25
7.41
g/l
—
10
46
5
23
2.21
0.99
1.2
1.7
—
—
—
0
0
118
1262
0.70
0.95
50.3
23.6
4.05
4.55
e12/l
14.29
113
1227
8
42
1.95
0.90
1.0
1.2
0.00
0.00
g/l
—
8
36
8
48
1.70
0.80
1.0
1.1
0.00
0.18
g/l
—
8
40
0
25
0.00
0.80
0.0
1.3
—
—
—
0
0
9
53
1.74
0.77
1.0
1.2
3.62
3.00
g/l
—
9
45
27
349
0.72
0.76
3.2
3.7
0.00
0.03
estimate
—
9
109
40
486
0.76
0.75
2.4
2.8
0.61
0.77
ug/l
1.39
26
327
7
43
1.66
0.68
1.6
1.4
—
—
—
0
0
92
839
1.25
0.62
5.2
3.4
14.76
14.93
pmol/l
0.25
87
753
10
66
1.55
0.54
2.9
4.3
—
—
—
0
0
31
256
1.27
0.50
1.5
1.8
1266.95
1186.74
nmol/l
0.13
22
205
51
575
0.83
0.47
3.5
4.3
33.70
51.93
ng/l
0.66
42
461
83
764
1.19
0.46
5.1
3.4
54.66
55.14
u/l
0.02
76
719
20
159
1.30
0.43
2.8
3.7
6.24
5.74
kpa
1.05
20
152
109
1144
0.83
0.42
36.1
14.9
83.83
75.10
ml/min/173m2
4.87
104
1066
0
19
0.00
0.39
0.0
1.2
—
149.46
—
0
19
5
36
1.40
0.38
1.2
1.3
—
—
—
0
0
5
36
1.40
0.38
1.2
1.3
—
—
—
0
0
85
895
0.88
0.27
4.1
4.3
17.09
12.32
mm/h
1.19
76
828
6
85
0.69
0.24
3.0
2.7
1.57
1.20
%
—
6
85
5
42
1.20
0.21
1.0
1.2
45.72
54.49
mg/l
—
5
35
5
42
1.20
0.21
1.0
1.2
34.06
38.84
mg/l
—
5
36
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
40.14
—
0
8
0
14
0.00
0.20
0.0
1.1
—
2.11
—
0
9
9
108
0.82
0.13
1.4
1.6
—
—
—
0
0
64
614
1.07
0.13
2.3
2.2
81.34
93.06
pmol/l
1.01
37
354
13
119
1.10
0.06
1.3
2.6
0.38
0.32
e6/l
0.10
13
113
25
263
0.94
0.06
1.4
1.7
1.35
1.25
mg/l
0.06
20
204
51
502
1.02
0.01
1.9
2.4
73.96
75.51
nmol/l
0.09
46
438
58
572
1.02
0.01
2.5
2.4
—
—
—
0
0
20
193
1.04
0.01
1.2
1.3
14.40
26.53
iu/ml
—
5
62
13
132
0.98
0.00
2.9
3.0
4.58
4.43
kpa
0.10
13
125
52
524
0.99
0.00
2.9
2.8
142.43
153.66
ug/l
0.16
43
484
0
5
0.00
-0.00
0.0
2.0
—
13.00
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
824.50
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.0
—
5.94
—
0
5
0
7
0.00
-0.00
0.0
2.0
—
270.43
—
0
7
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
39.21
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
1649.67
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_HYPOPHARYNX – Malignant neoplasm of hypopharynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).